Catalyst Wire Dossier Catalyst Wire Dossier

SEVIKAR Tablet

· Dong-A Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SEVIKAR Tablet, covering 2014-02-10 to 2014-02-10. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetic/Pharmacodynamic & Safety Study of G3041 and SEVIKAR® Tablet in Healthy Adult Volunteers [Phase 1]

See pricing